BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kiyasu Y, Akashi Y, Sugiyama A, Takeuchi Y, Notake S, Naito A, Nakamura K, Ishikawa H, Suzuki H. A Prospective Evaluation of the Analytical Performance of GENECUBE® HQ SARS-CoV-2 and GENECUBE® FLU A/B. Mol Diagn Ther 2021;25:495-504. [PMID: 34003471 DOI: 10.1007/s40291-021-00535-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Brümmer LE, Katzenschlager S, Gaeddert M, Erdmann C, Schmitz S, Bota M, Grilli M, Larmann J, Weigand MA, Pollock NR, Macé A, Carmona S, Ongarello S, Sacks JA, Denkinger CM. Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis. PLoS Med 2021;18:e1003735. [PMID: 34383750 DOI: 10.1371/journal.pmed.1003735] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
2 Kiyasu Y, Takeuchi Y, Akashi Y, Kato D, Kuwahara M, Muramatsu S, Notake S, Ueda A, Nakamura K, Ishikawa H, Suzuki H. Prospective analytical performance evaluation of the QuickNavi™-COVID19 Ag for asymptomatic individuals. J Infect Chemother 2021;27:1489-92. [PMID: 34301485 DOI: 10.1016/j.jiac.2021.07.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Akashi Y, Horie M, Kiyotaki J, Takeuchi Y, Togashi K, Adachi Y, Ueda A, Notake S, Nakamura K, Terada N, Kurihara Y, Kiyasu Y, Suzuki H. Clinical Performance of the cobas Liat SARS-CoV-2 & Influenza A/B Assay in Nasal Samples. Mol Diagn Ther 2022;26:323-31. [PMID: 35391608 DOI: 10.1007/s40291-022-00580-8] [Reference Citation Analysis]
4 Takeuchi Y, Akashi Y, Kiyasu Y, Terada N, Kurihara Y, Kato D, Miyazawa T, Muramatsu S, Shinohara Y, Ueda A, Notake S, Nakamura K, Suzuki H. A Prospective Evaluation of Diagnostic Performance of a Combo Rapid Antigen Test QuickNavi-Flu+COVID19 Ag. Journal of Infection and Chemotherapy 2022. [DOI: 10.1016/j.jiac.2022.02.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Naito A, Kiyasu Y, Akashi Y, Sugiyama A, Michibuchi M, Takeuchi Y, Notake S, Nakamura K, Ishikawa H, Suzuki H. The evaluation of the utility of the GENECUBE HQ SARS-CoV-2 for anterior nasal samples and saliva samples with a new rapid examination protocol. PLoS One 2021;16:e0262159. [PMID: 34972195 DOI: 10.1371/journal.pone.0262159] [Reference Citation Analysis]
6 Suzuki H, Akashi Y, Ueda A, Kiyasu Y, Takeuchi Y, Maehara Y, Ochiai Y, Okuyama S, Notake S, Nakamura K, Ishikawa H. Diagnostic performance of a novel digital immunoassay (RapidTesta SARS-CoV-2): A prospective observational study with nasopharyngeal samples. J Infect Chemother 2022;28:78-81. [PMID: 34736814 DOI: 10.1016/j.jiac.2021.10.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kiyasu Y, Owaku M, Akashi Y, Takeuchi Y, Narahara K, Mori S, Nagano T, Notake S, Ueda A, Nakamura K, Ishikawa H, Suzuki H. Clinical evaluation of the rapid nucleic acid amplification point-of-care test (Smart Gene SARS-CoV-2) in the analysis of nasopharyngeal and anterior nasal samples. J Infect Chemother 2021:S1341-321X(21)00363-9. [PMID: 35016829 DOI: 10.1016/j.jiac.2021.12.027] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]